Clinical trial
The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of…
NCT00303264 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00303264 |
|---|---|
| Title | The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia. |
| Official title | A Phase II Study to Investigate the Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia. |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dyspepsia |
| Intervention type | Drug |
| Interventions | dexloxiglumide, Nexium (esomeprazole) |
| Enrollment | 48 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Mar 16, 2006 |
| Last update posted | Mar 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: